Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy

Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy

Abstract Background Galectin‐3 (GAL3), a protein encoded by the LGALS3 gene, plays diverse roles in cancer initiation, progression, and drug resistance. Accordingly, high GAL3 expression in tumor cells is associated with poor prognosis in non‐small cell lung cancer (NSCLC). However, the prognostic i...

Full description

Bibliographic Details
Main Authors: Seiichiro Kusuhara, Satoshi Igawa, Masaaki Ichinoe, Ryo Nagashio, Yuki Kuchitsu, Yasuhiro Hiyoshi, Kazu Shiomi, Yoshiki Murakumo, Makoto Saegusa, Yukitoshi Satoh, Yuichi Sato, Katsuhiko Naoki
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:Thoracic Cancer
Subjects:
adjuvant chemotherapy
biomarker
galectin‐3
immunohistochemistry
non‐small cell lung cancer
Online Access:https://doi.org/10.1111/1759-7714.13945

Internet

https://doi.org/10.1111/1759-7714.13945

Similar Items